Discovery of potent STAT3 inhibitor with efficacy in model of IPF
Feb. 2, 2023
Scientists from Sichuan University and affiliated organizations have discovered a new signal transducer and activator of transcription 3 (STAT3) inhibitor, being developed as a potential therapeutic candidate against idiopathic pulmonary fibrosis (IPF).